2015Medical Journal of West ChinaRequires access

Sequential treatment studies in the elderly patients with community-acquired pneumonia

Zhou Xiao-yu

Open publisher page 0 citations

Abstract

Objective To analyze the efficacy of current clinical practice of sequential treatment of fluoroquinolones on elderly patients with community-acquired pneumonia(CAP).Methods The 130 patients from with CAP ≥65years were divided into moxifloxacin group and levofloxacin group,which were treated with moxifloxacin injection 400mg/d or levofloxacin 500mg/d followed by according pills if their symptoms improved after 2days,respectively.The total course was 7-14 days.The clinical and bacteriological results were observed and drug safety was assessed.Results The total course of treatment of moxifloxacin group was shorter than that of levofloxacin group.Moxifloxacin group cure rate and effective rate were higher than that of sequential treatment group.But both the risk of adverse reactions was equal.Conclusion Sequential treatment with moxifloxacin is better than sequential treatment with levofloxacin.But levofloxacin is cheaper than moxifloxacin.

About this research paper

What this paper is about

Objective To analyze the efficacy of current clinical practice of sequential treatment of fluoroquinolones on elderly patients with community-acquired pneumonia(CAP).Methods The 130 patients from with CAP ≥65years were divided into moxifloxacin group and levofloxacin group,which were treated with moxifloxacin injection 400mg/d or levofloxacin 500mg/d followed by according pills if their symptoms improved after 2days,respectively.The total course was 7-14 days.The clinical and bacteriological results were observed and drug safety was assessed.Results The total course of treatment of moxifloxacin group was shorter than that of levofloxacin group.Moxifloxacin group cure rate and effective rate were higher than that of sequential treatment group.But both the risk of adverse reactions was equal.Conclusion Sequential treatment with moxifloxacin is better than sequential treatment with levofloxacin.But levofloxacin is cheaper than moxifloxacin.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To analyze the efficacy of current clinical practice of sequential treatment of fluoroquinolones on elderly patients with community-acquired pneumonia(CAP).Methods The 130 patients from with CAP ≥65years were divided into moxifloxacin group and levofloxacin group,which were treated with moxifloxacin injection 400mg/d or levofloxacin 500mg/d followed by according pills if their symptoms improved after 2days,respectively.The total course was 7-14 days.The clinical and bacteriological results were observed and drug safety was assessed.Results The total course of treatment of moxifloxacin group was shorter than that of levofloxacin group.Moxifloxacin group cure rate and effective rate were higher than that of sequential treatment group.But both the risk of adverse reactions was equal.Conclusion Sequential treatment with moxifloxacin is better than sequential treatment with levofloxacin.But levofloxacin is cheaper than moxifloxacin.

Key concepts: Moxifloxacin, Levofloxacin, Medicine, Pneumonia, Community-acquired pneumonia, Pill, Cure rate, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Sequential treatment studies in the elderly patients with community-acquired pneumonia — Research Paper | ScholarLens